Φορτώνει......
The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy
Cancer immunotherapy and tumor microenvironment have been at the forefront of research over the past decades. Targeting immune checkpoints especially programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) has made a breakthrough in treating advanced malignancies. However, the low response rate...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Genes Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Impact Journals LLC
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305110/ https://ncbi.nlm.nih.gov/pubmed/30603054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/genesandcancer.180 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|